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Mononuclear leukocytes are able to destroy tumor cells under a  variety of circum- 
stances.  In  few  such  instances  is  the  biochemical  basis  of cytotoxicity understood. 
Recently,  we  demonstrated  that  activated  macrophages,  stimulated  by  phorbol 
myristate acetate (PMA), 1 secreted substantial amounts of hydrogen peroxide (1). The 
release  of this  oxidant  from  macrophages  correlated  with  the  extracellular  lysis  of 
tumor  cells  (2).  In  fact,  under  the  conditions  tested,  hydrogen  peroxide  was  both 
necessary and sufficient for cytolysis by activated macrophages (3). The secretion by 
phagocytic leukocytes of toxic species of reduced  oxygen can be triggered  not  only 
pharmacologically,  but  also  immunologically,  such  as  by  contact  with  antibody- 
coated  particles  or aggregated  immunoglobulin  (4-9).  Therefore,  we  attempted  to 
learn  whether  activated  macrophages would  lyse tumor cells  when  the  tumor cells 
were coated with homologous antibody, and whether reactive metabolites of oxygen 
would  play  a  role  in  this  form of cytolysis.  Tests  of these  hypotheses  are  reported 
below and in the accompanying paper (10). 
Materials  and Methods 
Mice.  Mice of either sex were obtained at 6-8 wk of age. CD2FI ([BALB/c ×  DBA/2]F1) 
mice were from Flow Laboratories, Inc. (Rockville, Md.), Charles River Breeding Laboratories, 
Inc.  (Wilmington,  Mass.),  or Simonson  Laboratories  (San  Francisco,  Calif.).  C57BL/6 and 
C57BL/10 mice were from The Jackson Laboratory, Bar Harbor, Maine, Trudeau  Institute, 
Saranac Lake, N. Y., and Charles River Breeding Laboratories, Inc. A/Sn mice were from The 
Jackson Laboratory. 
Injection  of Eliciting Agents and Harvest of Peritoneal  Cells.  Bacille Calmette-GuSrin  (BCG)  (7 
×  106 viable organisms, Pasteur type 1011, Trudeau Institute), heat-killed Co(ynebacterium parvum 
(0.7 mg, Burroughs-Wellcome, Research Triangle Park, N. C.), and thioglycollate broth (1 ml 
of a  10%  solution,  Difco  Laboratories,  Detroit,  Mich.)  were  injected  intraperitoneally  as 
described (1). Peritoneal cells were collected from untreated mice (resident cells);  12-20 h after 
injection of thioglycollate broth (granulocytes); 3-5 d after thioglycollate broth; 5-7 d after C 
parvum;  or  10  d-5  wk  after  BCG (BCG  cells).  The  collection,  hypotonic  lysis,  washing, 
enumeration, and differential counting of peritoneal cells were as before (1). Differential counts 
during this study were the same as those given elsewhere (1, 2). 
Tumor  Cells.  Tumors were passaged as ascites.  P388 was maintained  in CD2F1 mice, and 
TLX9 in C57BL/6 mice (2). YAC-1 was the kind gift of R. Keller, Immunobiology Research 
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KRPG that contained 1% FBS; MEM, Eagle's minimum essential medium; MEMS, MEM that contained 
10% FBS; NK, natural killer; PMA, phorbol myristate acetate. 
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Group, Ziirich, and also of E.  Lattime and O. Stutman, Memorial Sioan-Kettering Cancer 
Center,  New  York,  and  was  maintained in A/Sn  mice.  EL4-BU  and  Russian  Leukemia 
(C57BL/6 mice), and L1210/CTX and P388/adria (CD2FI mice), were from the Division of 
Cancer Treatment, National Cancer Institute (Bethesda,  Md.).  Erythrocytes were  lysed  by 
hypotonic shock (1) if they represented >1% of the cells. Equivalent results were obtained when 
tumors were maintained  as stationary suspension  cultures in Eagle's minimum  essential medium 
(MEM)  alpha modification with  100  U/ml penicillin and  100 #l/ml streptomycin (Grand 
Island Biological Co., Grand Island, N. Y.) that contained 10% heat-inactivated (56°C for 30 
min) fetal bovine serum (FBS) (Flow Laboratories, Inc.) (MEMS) at 37 ° in 5% CO2 in air. 
Sera.  Spleens were  removed  aseptically from  CD~F]  mice  (H-2a),  or  from  C57BL/6 or 
C57BL/10 mice (H-2b), placed in MEM, and crushed with a sterile glass stopper. One-seventh 
of a spleen was injected intraperitoneally into mice of the opposite H-2 type every other week 
for three to six injections. Results were equivalent, but titers were higher, if the spleens were 
taken from mice that had received BCG intraperitoneally. 1 wk after the last injection, blood 
was collected, and the serum was frozen at -80"C until use. Results were unaffected by heating 
the serum at 56°C for 30 min. Mouse serum used as a complement source was collected from 
the donors of the peritoneal cells in the same experiment. 
Labeling and Sensitization of Tumor Cells.  Tumor cells  were  labeled with sodium 51Cr and 
washed four times as described (2). Up to 1 ×  10  e cells were then suspended in 0.1 ml of Krebs- 
Ringer phosphate with glucose  (1)  that contained 1% FBS (KRPGS) and variable amounts 
(Results)  of alloantiserum. After 30 min on ice, 0.1  mi of 40% fresh mouse serum in KRPGS 
was added, giving a final concentration of 20%, and the cells were incubated for  10 min in a 
37°C water bath. The cells were then washed one to three times by centrifugation, or diluted 
directly in MEMS.  As controls, alloantiserum was replaced with nonimmune mouse serum 
from the same strain of mice (sham sensitization), or mouse serum was omitted (unsensitized 
cells). The final concentration of mouse serum in the assay with sensitized or sham-sensitized 
cells ranged from 0 to 3% (usually <0.3%) without affecting the results. 
Cytotoxicity Assay.  Variable numbers of peritoneal cells  (usually 1 ×  10  n) and tumor cells 
(usually 2 ×  104 to 4  ×  104) were dispensed at 4°C to  12- ×  75-mm glass  tubes in 2 ml of 
MEMS  (the  FBS  concentration was  usually  1 or  5%,  but  ranged  from  0.1  to  10%  with 
equivalent results).  The tubes were centrifuged (180 g for 5 min), warmed for 60 s in a 37°C 
water bath, and incubated for 4.5-8 h at 37°C in 5% CO2 in air. The tubes were centrifuged 
at 700 g for 10 min, and the upper 1 ml removed to another tube. Controls received 10-100 ng/ 
ml of PMA as before (2). In separate experiments, 4.8:1:  1.4% of the radioactivity remained 
associated  with the tubes after gentle washing with warm KRPG at the end of the assay. This 
retention of SlCr was not affected by the presence or absence of effector cells, nor by the use of 
sensitized,  sham-sensitized, or  unsensitized target  cells.  Thus,  effector  cells  did  not  retain 
detectable radiolabel from the target  cells.  Equivalent results were obtained with microtest 
plates (Costar,  Data Packaging, Cambridge, Mass.).  In this case, 8 ×  105 to 9 ×  105 peritoneal 
cells and 2 ×  104 to 4 ×  104tumor cells were incubated in 0.2 ml of MEMS/6.4-mm well. The 
percent specific release of 5XCr was calculated as before (2), except that in the plate assay, 0.1 
ml of supernate was removed for counting, and the total radioactivity per well was estimated 
by counting portions of the initial tumor cell suspension. The simple proportional standard 
error of the mean (2) is reported for triplicates. 
Depletion of Macrophages with Monoclonal Antimacrophage Antibody.  Dr.  Ralph Steinman (The 
Rockefeller  University, New York) kindly provided the IgG fraction of a DEAE column eluate 
of ascites from a hybridoma (1.1). 14/.tg of 1.1 protein in 1 m] of Tris buffer, pH 9, was added 
to 35-mm plastic culture dishes  (Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, 
Calif.)  at room temperature for  1-6 h. The dishes were rinsed six times with KRPG and then 
given 2 ×  l0  s BCG peritoneal cells that were nonadherent to untreated plastic tissue culture 
dishes after 2 h of incubation in MEM-5% FBS. The 1.1-treated dishes were centrifuged (150 
g  for  2  min) and  incubated at  37°C  for  60-90  min. The  medium was  collected,  and  the 
monolayer was jetted gently with warm KRPG from a  pipette. The nonadherent cells were 
pooled and washed by eentrifugation. 
Other Monoclonal Antimacrophage Antibodies.  2.4G2  and its Fab were prepared as described 
(11).  2.6 and its  Fab were  prepared  by the same techniques (I.  Mellman, R.  Steinman, J. NATHAN,  BRUKNER,  KAPLAN,  UNKELESS,  AND COHN  185 
Unkeless, and Z. Cohn. Manuscript in preparation.). Their specificities are shown in the legend 
to Fig.  6. 
Scanning Electron Microscopy.  Samples were processed as described (2). 
Results 
Lysis of  Sensitized Lymphoma Cells by Various  Populations of  Peritoneal Cells.  In an earlier 
study, when mice were injected with BCG or C. parvum, their peritoneal macrophages 
acquired the capacity to release copious amounts of hydrogen peroxide in the presence 
of PMA (1), and thereby to lyse lymphoma cells (2, 3). In the present study, peritoneal 
cells from such mice lysed TLX9 or P388 lymphoma cells,  not only in the presence of 
PMA (Table I), but also when the tumor cells had been sensitized with alloantiserum 
and fresh mouse serum (FMS)  (Table I). The results  in Table I were obtained with 
three different  alloantisera for each tumor. Similar alloantiserum-dependent cytolysis 
by BCG peritoneal cells was observed in smaller numbers of experiments with four 
additional lymphoma targets (EL4-BU, Russian Leukemia, L 1210/CTX, and P388/ 
adria)  (not shown). 
In contrast to the results with activated peritoneal cell populations, peritoneal cells 
from untreated mice, or those elicited with thioglycollate broth, were unable to lyse 
sensitized lymphoma cells  (Table I).  Such peritoneal cells were previously found to 
release  little  hydrogen  peroxide in  response to PMA  (1).  As before  (2),  they  lysed 
lymphoma cells poorly in the presence of PMA (Table I). 
Granulocyte-rich  peritoneal  cell  populations were highly effective  in  lysing lym- 
phoma cells in the presence of PMA (Table I; [2]). However, the same cell populations 
failed to lyse sensitized TLX9 cells (Table I). 
Dependence of Cytolysis on Concentration  of AUoantiserum and FMS.  The extent of lysis of 
TABLE  I 
AUoantiserum-dependent Lysis of Lymphoma Cells by Activated Peritoneal Cells 
Tumor  Peritoneal  cells  E:T ratio* 
Mean percent  specific  relc~.~e of ~UCr ±  SEM (number of experiments):~ 
Sensitized§  Sham scnsitizs:d  u  Unsensitized¶ 
Sham or unscnsi- 
tizcd plus 
PMA** 
TLX9  BCG:~c  24±5  65,1 ±  2,7 (30)  12.9±2.0(22)  8.3±2.5(13)  57.9±4.1  (23) 
C. far0um~  40±18  38.4 ±  15.1 (3)  10.3±6.2(2)  8.9 ±  ],B (2)  51.0±24.3(3) 
Thioglycollat~ N  63±27  6.72:1.2(3)  1.7 ±  5.1  (2)  -3.9 ±  1.7 (2)  3.7±1.3(3) 
Resident¶¶  282:7  1.82:3.0(8)  -4.6±2.3(6)  -4.32:1.0(6)  1.12:1.1(7) 
Granulocytes***  54 +  16  3.8 ±  1.3 (4)  0.5 ±  1.6 (3)  -0,7 ±  0.3 (3)  73.2 2:19,7 (4) 
P388  BCG  262:3  41.62:5.1(10)  7.0 2:2.2 (10)  9.7±7.6(2)  69.8±7.5(9) 
Resident  26 4" 4  4.9 4" 2.3 (3)  1.3 (I)  2.4 2:3.0 (2)  2.8 2:2.0 (2) 
* The E:T ratio is calculated  from tbe qumber of macrophages and monocytcs added,  except where indicated  for granulocytcs.  The target 
cells were 2 X  104-4 X  104/culture. 
~c Spontaneous  release for TLX9 ~veraged: sensitiz'.ed, 15.9 ±  0.8; sham sensitized,  15.1  +  O.&  umcnsitizcd,  15.6 2:  1.4:  with PMA,  11.4 + 
0.5. Maximum release after freezing and thawing averaged  86.7 ±  0.7. The corresponding  v~rlucs for P388 were:  18.6 ±  1.5,  15.0 ±  1.0, 
16.2"+  1.7,  17.2±  1.4, and 89.3 ±  0.8. 
§ Target cells incubated  with one of three  alloantisera  directed  against  either T|,X9 or P3BB, followed  by exposure to 20~  FMS. before 
dilution and addition to effector ce21s. 
H Target cells prepared  as in §, but with nonlmmune mouse serum in place of alloanti~rum. 
¶  Target cells not exposed to mouse serum. 
*" PMA, 10-100 ng/ml. 
~:~ From mice given 7 X  I0  e viable BCG i.p. from  I0 d-5 wk before  collection. 
From mice given 0.7 mg heat-killed C. ~rvum 5-11 d before  collection. 
NH From mice given  ] ml of 10'7~ thioglycollate  broth 3-5 d before collection. 
¶¶ From untreated  mice. 
*** From mice given thioglycollare  broth  12-20 h before collection. 186  ACTIVATED MACROPHAGES  IN  ANTIBODY-DEPENDENT LYSIS 
TLX9 by BCG peritoneal cells depended  upon  the concentration  of alloantiserum 
used for sensitization  (Fig.  1). Lysis by BCG peritoneal cells was augmented slightly 
by including  10% or more FMS in the sensitization step (Fig.  1). Up to 20% FMS did 
not cause antibody-dependent lysis in the absence ofeffector cells, although 50% FMS 
did so to a  minor degree  (Fig.~ 1).  With  rabbit serum as a  complement source,  the 
alloantisera typically lysed  100%  of lymphoma cells at dilutions  of 1:60-1:200,  and 
gave 50% lysis at  1:500-1:1,200.  Sensitization was routinely performed with  1:5-1:20 
alloantiserum, followed by 1:5  FMS, before dilution and mixture with effector cells. 
Results were the same if the target cells were washed repeatedly after the sensitization 
step. 
Specificity and Contact Dependence of Cytolysis.  Five experiments with similar results 
were performed to determine whether the lysis of sensitized lymphoma cells by BCG 
peritoneal  cells was  immunologicaUy specific.  As  shown  in  Table  II  for one  such 
experiment, BCG peritoneal cells lysed TLX9 when the ailoantiserum was directed 
against TLX9, and  lysed  P388  when  the alloantiserum  was directed  against  P388. 
However, no lysis of TLX9 above background occurred with anti-P388 alloantiserum, 
and no lysis of P388  above background occurred with anti-TLX9 alloantiserum.  In 
addition, no lysis above background of either lymphoma occurred in the presence of 
unlabeled,  sensitized  lymphoma cells  of the  other  type.  This  was  not  a  result  of 
interference by the  increased  number of target cells present,  because cytolysis pro- 
ceeded  normally  in  the  presence  of  P388  cells,  if TLX9  cells  were  labeled  and 
sensitized,  and  vice versa  (Table II). Furthermore,  PMA-induced  cytolysis of each 
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FIG.  1.  (Upper panel) Effect of concentration of alloantiserum on lysis of 2 X  104 TLX9 ceils  by 
a  75-fold  excess of BCG peritoneal cells  (containing 44%  macrophages and  monocytes) over 8  h. 
O  C), no FMS added as a complement source during the sensitization step; 0-- - -0, 10% FMS 
added; @- - -@, 50% FMS added; C), eytolysis  in the absence of antiserum but in the presence of 
PMA. Means of triplicates. SEM ranged from 0.1 to 4.8% (mean: 1.8%). (Lower  panel) Spontaneous 
release of 5]Cr by TLX9 cells in the absence of effector  cells, as influenced by the concentration of 
alloantiserum and FMS during the sensitization step. NATHAN, BRUKNER,  KAPLAN, UNKELESS,  AND  COHN  187 
TABLE  II 
Specificity of Alloantiserum-dependent Lysis by BCG Peritoneal Cells 
Tumor* 
5aCr-labeled  Unlabeled 
Alloantiserum di-  PMA  Percent specific re- 
rected against  lease of 5~Cr:]: 
TLX9  --  Neither§  --  27.6 ±  1.6 
TLX9  --  TLX9  --  90.5 :t: 1.7 
TLX9  --  P388  --  24.0 ±  1.3 
P388  --  Neither  --  13.6 3= 1.2 
P388  --  P388  --  71.8 :t: 1.4 
P388  --  TLX9  --  13.7 3= 1.3 
TLX9  P388  TLX9  --  77.2 :l: 7.5 
P388  TLX9  TLX9  --  10.5 3= 1.3 
P388  TLX9  P388  --  67.1:1:0.9 
TLX9  P388  P388  --  32.1 3= 1.5 
TLX9  --  Neither  +  88.2 3= 2.1 
TLX9  P388  Neither  +  87.7 3= 0.7 
P388  --  Neither  +  90.1  :t=  1.0 
P388  TLX9  Neither  +  88.2 3= 8.7 
* 2 ×  104 cells incubated with a  54-fold excess of macrophages  from BCG-treated 
Spontaneous release was 17.4 3= 0.4% for TLX9 and 16.1 3= 1.2% for P388 in 7 h. 
:~ Mean :t= SEM for triplicates. 
§ Nonimmune mouse serum used in place of alloantiserum. 
mice. 
lymphoma was unaffected by the presence of the other (Table II). Thus, cytolysis of 
sensitized lymphoma cells was immunologically specific. Moreover, it appeared to be 
effective only against target cells in antibody-dependent contact with the effector cells 
because bystander cells were completely spared. 
Characterization of Cytolysis by  Scanning Electron Microscopy.  Sensitized  TLX9  cells 
appeared morphologically normal, with numerous surface microvilli, when observed 
within 10 min of their addition to BCG peritoneal cells (Fig. 2 a). By 30 min, however, 
some of the lymphoma cells had  lost microvilli, and displayed surface pitting (Fig. 
2 b). By 1 h, most of the lymphoma cells exhibited pitting, and some were replaced by 
collections of cellular debris (Fig. 2 c). At 3  h  (Fig. 2 d) and  7 h  (Fig. 2 e), almost no 
intact TLX9 cells remained, whereas collections of rubble-like material were evident 
on many of the macrophages. In contrast, sham-sensitized TLX9 cells incubated with 
BCG peritoneal cells were still morphologically normal at 7 h  (Fig. 2 f), and sensitized 
lymphoma cells were unaffected by 7 h  incubation with resident peritoneal cells (Fig. 
2 g). All damaged TLX9 cells seen were in contact with macrophages. A  minority of 
damaged TLX9 cells were also adjacent to lymphoeytes. No freestanding TLX9 cells 
were observed to be damaged. The number of damaged TLX9  cells in contact with 
the same macrophage ranged from one to three.  No phagocytosis of lymphoma cells 
was detected. 
Time-Course of Cytolysis.  The  rapidity of cytolysis observed  by  scanning  electron 
microscopy was confirmed by 51Cr release. In the presence of BCG peritoneal cells, 
half-maximal specific release of 51Cr from sensitized TLX9 cells occurred by 1 h, and 
maximal release by 5  h  (Fig. 3).  With less potent  alloantisera, maximal  release was 
sometimes  delayed to 8  h  (not  shown).  In  contrast,  peritoneal cells from  untreated 
mice lysed sensitized TLX9 cells poorly even after 20 h  of incubation (Fig. 3). 
Effector:Target Ratios.  Lysis of sensitized TLX9  cells by BCG  peritoneal cells was 188  ACTIVATED  MACROPHAGES  IN  ANTIBODY-DEPENDENT  LYSIS 
Fro.  2.  Scanning electron  micrographs  of sensitized  (a-e,  g)  or  sham-sensitized  (f)  TLX9  cells, 
incubated with BCG peritoneal cells (a-f) or resident cells (g), for the following times:  (a)  10 min, 
x  2,3.50;  (b) 30 min, X  2,270;  (c)  I  h, x  2,800;  (d) 3 h, x  2,000;  (e)  7 h, x  3,700;  (f)  7 h, x  1,200; 
(g)  7 h, X  1,200. NATHAN,  BRUKNER,  KAPLAN,  UNKELESS,  AND  COHN 
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Fic.  3.  Time-course of cytolysis  of 4  X  104 sensitized TLX9 cells by  1.9 x  l0  s BCG cells (0) 
(containing 45%  macrophages and  monocytes)  or  1.5  ×  106 resident cells  (&)  (containing 44% 
macrophages and monocytes) in 2 mi of MEM-5% FBS.  (O and A) are corresponding values with 
sham-sensitized TLX9 cells in the presence of PMA. At the indicated time points, beginning with 
1 h, spontaneous release averaged 5.7, 9.2,  11.0, 14.3, 17.5, arid 25.8%. Means :t: SEM of triplicates. 
189 
75 
'O 
O. 
25 
~P~N 
~cP 
J  BCG 
CP 
Effeclor :forget ratio 
F~e. 4.  Effect of peritoneal cell number on lysis of 2 ×  104 sensitized TLX9 ceils Cclosed symbols) 
over 8 h in 12- ×  75-mm tubes. Resident cells (Res)  contained 58% macrophages and monocytes; 
BCG cells,  44%;  C.  panmm cells  (CP),  50%;  and  thioglycollate broth-elicited ceils (Thio), 92%. 
Polymorphonuclear leukocyte-rich exudates (PMN) contained 60% granulocytes. For comparison, 
the E:T  ratios are  expressed  in  terms of the  presumptive effector ceils  indicated above.  Open 
symbols, unsensitized TLX9 cells plus PMA. Means :t: SEM of triplicates. 
half-maximal at effector:target (E:T) ratios of -~9 (expressed in terms of the macro- 
phages and  monocytes present)  when tested in  12-  ×  75-ram  glass tubes  (Fig.  4). 
When tested in microtest wells, half-maximal lysis required E:T ratios of ~3, although 
maximal lysis tended to be lower (Fig. 5). Results were the same whether the effector 
or the target cell number was varied, or whether the microtest wells had flat, round, 
or conical bottoms  (not  shown).  The  relative inability of resident,  thioglycollate- 190  ACTIVATED  MACROPHAGES  IN  ANTIBODY-DEPENDENT  LYSIS 
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Fro.  5.  Effect of 3.3 X 10  s BCG-activated macrophages on 5~Cr release from sensitized TLS9 cells 
(0)  ranging from  1 ×  104 to 4  ×  105/6.4-mm  well.  (0)  represents unsensitized TLX9 cells  plus 
PMA. Specific release from unsensitized TLX9 cells in the presence of BCG cells without PMA was 
-1.6 ±  1.3%. Means ±  SEM of triplicates. 
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TABLE III 
Lysis of Sensitized TLX9 Cells by Peritoneal Cell Subpopulations 
BCG peritoneal cells 
Nonadher- 
Experi-  Assay  Nonad-  ent to plas-  Nonphag- 
ment  Unsepara-  Adherent  herent to  tic coated  ocytic ad- 
ted*  :~  plastic§  with 1.1 an-  herent 
tibodylj  cells¶ 
A  Percent SlCr release**  32.5  21.9  13.3  ND:~  -0.4 
Percent macrophages§§  32.8  ND  21.0  ND  1.7 
B  Percent ~lCr release  24.8  22.4  28.2  5.9  ND 
Percent macrophages  42.9  ND  22.5  5.6  ND 
C  Percent S~Cr release  54.2  30.8  19.8  5.8  ND 
Percent macrophages  45.2  ND  17.7  5.8  ND 
* 9  ×  105 BCG peritoneal cells were incubated with 2 ×  104 TLX9 cells  in 6.4-ram microtest wells  in 
MEM-5% FBS. 
:~ 9 ×  105 cells were allowed to adhere to the wells for 3 h, or 3 ×  105 fresh cells were allowed to adhere 
successively three times for 1 h each, with repeated rinsing of the monolayers. 
§ Cells were decanted after gently agitating a tissue culture plastic dish in which they had been incubated 
for 3 h. 5 ×  105 cells/well were used as effectors. 
H  Cells nonadherent after 2 h as in § were centrifuged onto dishes coated with the monoclonal antimacro- 
phage antibody, 1.1. Cells nonadherent to l.l-treated dishes were used at 5 ×  105/well. 
¶ Prepared as elsewhere (12), and used at 5 ×  10S/well. 
** Specific  release for sensitized TLX9 less specific release for sham-sensitized TLX9. 
:~:~ ND, not done. 
§§ Differential counts of macrophages and monocytes were performed on cytocentrifuge slides as elsewhere 
(1). 
induced,  and  granulocyte-rich  peritoneal  cells  to  lyse  sensitized  TLX9  cells  was 
preserved over a  wide range of E:T  ratios (Fig. 4). 
Nature of the Effector  Cell.  When  BCG  peritoneal  cells  were  allowed  to  adhere  to 
plastic  in the presence of FBS,  both  the adherent  and  the nonadherent  populations 
lysed sensitized TLX9  cells  (Table III).  However,  under  such conditions, the nonad- 
herent population  contained  a  substantial  proportion  of morphologically  identifiable 
macrophages  and  monocytes  (22.2  :is  1.3%  in  23  experiments)  (morphologic  criteria 
in:  [1]).  Mononuelear  phagocytes  were  not  reduced  below  14%  of the  nonadherent NATHAN, BRUKNER, KAPLAN, UNKELESS, AND COHN  191 
cells by using tissue culture plastic or glass from six different manufacturers, eight lots 
of FBS,  or  up  to  three  cycles  of adherence.  Therefore,  we  tested  a  monoclonal 
antimacrophage antibody, 1.1. This reagent gave strongly positive indirect immuno- 
fluorescence with mouse peritoneal macrophages, but only weak or negative reactions 
with lymphocytes from mouse peritoneum or spleen  (R.  Steinman.  Personal com- 
munication.). In three experiments, BCG peritoneal cells nonadherent to  1.1-coated 
dishes contained from 0 to 5.8% (mean: 3.8%) of morphologically identifiable mono- 
nuclear phagocytes. 96% of the cells were lymphocytes by morphology. The ability of 
such populations to lyse sensitized TLX9 cells was  markedly reduced  (Table  III). 
However, some cytolytic capacity remained, which appeared  to correspond  to the 
residual  proportion  of mononuclear phagocytes  (Table  III).  Supernates  from  the 
incubation of peritoneal cells in 1.1-treated dishes did not reduce cytolysis when used 
to resuspend unseparated or conventionally prepared nonadherent cells, thus suggest- 
ing that immune complexes were not released from such dishes to exert a  blocking 
effect  (not  shown).  The  adherent  population  of  BCG  peritoneal  cells  has  been 
characterized in detail  (12).  In addition to macrophages, it contains up  to  18% of 
nonphagocytic cells bearing Fc receptors, which are probably B lymphoblasts (12). 
When  these  nonphagocytic adherent cells were  isolated, they were  unable  to  lyse 
sensitized TLX9 cells (Table III). 
Role  of the  Trypsin-resistant  Fc  Receptor  The  results  to  this  point  suggested  that 
specific interaction of antibody-coated lymphoma cells with BCG-activated macro- 
phages could elicit an extracellular cytotoxic response similar to that elicited with the 
pharmacologic agent,  PMA.  To  obtain  more  direct  evidence  regarding  a  ligand- 
receptor interaction triggering cytotoxicity, we pretreated BCG cells with a  mono- 
clonal antibody, 2.4G2, which specifically recognizes the trypsin-resistant Fc receptor 
(FcR II) on mouse peritoneal macrophages (11). Because antimacrophage antibodies 
may  block  macrophage  Fc  receptors  nonspecifically, presumably  by  interactions 
involving the Fc of the antibodies (13), we included two controls. First, we used Fab 
of the anti-Fc receptor antibody. Second, we examined the effect of another mono- 
clonal antimacrophage antibody, 2.6, which recognizes a 21,000-dalton surface moiety 
distinct from, and at least five times as abundant as FcR II. (I. Mellman, R. Steinman, 
J. Unkeless, and Z. Cohn. Manuscript in preparation.). Like 2.4132, 2.6 was used both 
intact  and  as  Fab.  As  shown  in  Fig.  6A,  2.4G2  markedly  inhibited  the  lysis of 
sensitized  TLX9  ceils  by  BCG  peritoneal  cells.  In  four  experiments,  inhibition 
averaged  82  and  74%  for  optimal  doses  of the  intact  antibody  and  its  Fab.  In 
individual experiments, this inhibition reached 100 and 97%, respectively. Inhibition 
was  specific  for antibody-dependent cytolysis, because  there  was  no  inhibition of 
PMA-dependent cytotoxicity against sham-sensitized TLX9 cells (Fig. 6 B). In addi- 
tion, 2.6 and its Fab had no inhibitory effect (Fig. 6). 
Spontaneous Lysis of Unsensitized  Cells.  In  the  absence  of alloantiserum or  PMA, 
BCG cells rarely caused substantial lysis of TLX9. Thus, in 36 experiments in which 
TLX9 cells were treated with nonimmune alloserum before incubation with BCG 
cells, specific release of SlCr averaged 5.7:1: 0.7%. However, there were eight additional 
experiments, performed in the same manner, in which cytolysis averaged 26.7 +  2.9%. 
This was suggestive of natural killer (NK) activity (14). Therefore, experiments were 
conducted with YAC lymphoma, which is highly sensitive to lysis by NK cells (14). 
When 2 ×  104 unsensitized YAC cells were incubated with 9 ×  105 BCG peritoneal 192  ACTIVATED  MACROPHAGES IN  ANTIBODY-DEPENDENT  LYSIS 
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FIG. 6.  Effect of two monoclonal antimacrophage antibodies and their Fab on cytolysis of 2 X 104 
lymphoma cells by 8 ×  105 BCG peritoneal cells (51  =l= 3% macrophages and monocytes)  per well 
over 7 h in microtest plates. (A) Antibody-dependent  cytolysis ofTLX9. (B) PMA-induced cytolysis 
ofTLX9. (C) Spontaneous cytolysis of  YAC. O, intact 2.4(32 IgG; O, Fab of 2.4G2; 2.4G2 recognizes 
the trypsin-resistant receptor on mouse macrophages for the Fc of aggregates of IgGl or IgG2b (11). 
A, intact 2.6 IgG; A, Fab of 2.6; 2.6 recognizes a 21,000-dalton  surface antigen that is at least five 
times more abundant than the FcR (I. Mellman, R. Steinman,J. Unkeless, and Z. Cohn. Manuscript 
in preparation.). Means and SEM are shown for four experiments, ofwhich two included YAC, and 
are expressed as percentage of the values obtained without antimacrophage antibodies. The latter 
values were: TLX9, sensitized, 45.1 + 8.0%; TLX9, sham sensitized, plus PMA, 65.7 :t= 5.9%; YAC, 
unsensitized, 42.8 :t= 11.7%. Specific release from sham-sensitized  TLX9 calls in the absence of PMA 
but in the presence of BCG cells and antimacrophage antibodies averaged 9.6%, compared with 
8.4% without antimacrophage antibodies. Effector cells were incubated for 30 min at 4°C with the 
indicated concentrations of antimacrophage antibodies before tumor cells were added. 
cells, there was 50.0 :l: 8.1% specific release of 5aCr (eight experiments). Lysis of YAC 
was  not  observed  after  incubation  with  resident  peritoneal  cells  or  thioglycollate 
broth-elicited mononuclear cells or granulocytes (not shown). In contrast to antibody- 
dependent cytotoxicity, lysis of YAC was not inhibited by antibody against  FcR II 
(Fig. 6C). Thus, peritoneal cells from mice given BCG could mediate both antibody- 
dependent and spontaneous cytolysis in short-term assays, the most prominent form 
depending upon the target cell. 
Discussion 
We conclude that  tumor cells coated with specific, homologous immunoglobulin 
interact  with  at  least  one class  of Fc  receptors  (FcR  II)  (11)  on  activated  mouse 
peritoneal  macrophages.  The  interaction  triggers  rapid  and  potent  extracellular 
cytolysis, limited to the tumor cells in antibody-dependent contact with the macro- 
phages. 
Two lines of evidence support the interpretation that mononuclear phagocytes were 
responsible for most of the lysis  of sensitized lymphoma cells.  By scanning electron 
microscopy, damaged tumor cells were always observed in contact with macrophages. 
Damaged tumor cells were sometimes seen in contact with lymphocytes at the same 
time as with macrophages, but were not  found associated with lymphocytes alone, 
nor standing free. Morphologic injury was evident by 30 min and was extensive by 1 
h.  The  simplest  explanation  for these  observations  is  that  macrophages  were  the NATHAN, BRUKNER, KAPLAN, UNKELESS, AND COHN  193 
predominant effector cells.  Alternative explanations would have to be complicated; 
for example, that lymphocytes injured only those target cells in contact with macro- 
phages  and  then  quickly withdrew.  Second,  cytolytic activity was  present  in  the 
adherent  population,  where  it  could  not  be  attributed  either  to  nonphagocytic 
adherent cells (lymphoid cells with Fc receptors  [12]) or to granulocytes. Cytolytic 
activity was present also in the nonadherent population, where it correlated with the 
number of nonadherdnt mononuclear phagocytes identified by morphologic criteria. 
Depletion of the latter cells, by incubation on  dishes coated with antimacrophage 
antibody, led to a  corresponding depletion of cytolytic activity, down to a  level of 
-6%. However, as with macrophage-depletion techniques based on the use of silica, 
carrageenan,  iron,  glass,  plastic,  Sephadex,  or  nylon,  it  is  possible  that  a  minor 
population of cells other than macrophages may also have been selectively affected. 
Thus, the data are most consistent with the mediation of alloantiserum-dependent 
cytolysis  by  mononuclear  phagocytes  under  the  conditions  tested.  The  possible 
participation of other cell types is not excluded. 
The ability of macrophages to lyse antibody-coated tumor cells has been contro- 
versial. According to the present results, many of the earlier negative reports  (e.g., 
[15-20])  may have been  influenced by the use of resident  or inflammatory rather 
than  activated  macrophages.  For  example,  Ojo  and  Wigzell  (19) studied  mouse 
peritoneal cells 3 d after injection of C. parvum, an interval that in our experience was 
too brief to result in macrophage activation (1). The only cells in such populations 
capable of lysing alloantiserum-coated P815 cells appeared to be NK cells (19). 
In contrast, there are many reports that testify to the ability of various mononuclear 
phagocyte populations to lyse antibody-coated tumor cells or cell lines. Effector cells 
in such studies have come from the peritoneal cavity (21-28), bone marrow cultures 
(29, 30), tumor tissue (31, 32), peripheral blood (33, 34), or macrophage cell lines (35, 
36).  Only  a  few  studies,  however,  have  described  a  rapid,  potent,  lytic  process 
mediated by primary tissue macrophages against tumor cells coated with antibody 
from  the  same  species  (24-26).  Likewise, few studies  have  considered  the  role  of 
macrophage activation in antibody-dependent lysis of tumor cells (e.g.,  [24,  28,  35, 
36]). 
Perhaps the only previous study to combine these features was that of Yamazaki et 
al. (24). Those workers observed that resident peritoneal macrophages failed to lyse 
syngeneic, ~iCr-labeled  mammary adenocarcinoma cells  sensitized  with  syngeneic 
anti-tumor IgG2a. However, adherent peritoneal cells from mice given BCG, bacterial 
lipopolysaccharide, or glycogen were able to mediate cytolysis (24).  Yamazaki et al. 
(24)  proposed  that  the cytotoxicity observed  by many workers using macrophages 
from  specifically immunized mice  might  reflect  a  two-stage  process:  lymphocyte- 
mediated macrophage  activation, followed by antibody-dependent cytotoxicity by 
activated macrophages. 
Joiley et al. (25) observed [125I]iododeoxyuridine release from alloantiserum-coated 
mouse lymphoma cells incubated for 20 h  with resident peritoneal cells.  The same 
peritoneal cells inhibited DNA synthesis by unsensitized tumor cells (25),  raising the 
question of whether the macrophages were activated, perhaps by intercurrent infec- 
tion. Indeed, strong evidence supporting that possibility was provided elsewhere by 
the same workers (37).  Several investigators have observed lysis of sensitized, virus- 
infected  cell  lines  by  resident  peritoneal  cells  (23,  26,  27).  Such  populations  of 194  ACTIVATED MACROPHAGES IN ANTIBODY-DEPENDENT LYSIS 
peritoneal cells failed to lyse sensitized tumor cells in the present study. The reasons 
for the discrepant results are not clear, but the possibility should be considered that 
cell  lines  may  become  more  susceptible  to  cell-mediated  cytotoxicity after  viral 
infection. 
Monoclonal anti-FcR II (I 1) and its Fab markedly inhibited antibody-dependent, 
cell-mediated cytolysis. Inhibition was specific, in that  monoclonal anti-FcR II did 
not  affect PMA-induced cytolysis by the same effector cells, nor was  inhibition  of 
antibody-dependent cytolysis observed with a monoclonal antibody directed against 
a more abundant macrophage surface antigen that was distinct from FcR II. 
Based on their lysis of unsensitized YAC cells, the peritoneal cells from BCG-treated 
mice used in this study may have contained NK cells (38). The role of the Fc receptor 
in  the  cytolytic function  of NK  cells  is  disputed.  Aggregated  IgG  (39),  immune 
complexes (40), and anti-immunoglobulin (39)  have been reported to block NK cell 
function in man,  but  aggregated IgG did not  do so in the mouse  (41).  Our results 
with monoclonal antibody to FcR II suggest that this receptor was not required for 
spontaneous cytolysis of YAC, whatever effector cell was involved. 
We found that populations of mononuclear phagocytes that were previously shown 
to release substantial  amounts of hydrogen peroxide in  response to PMA  (1)  were 
capable of lysing antibody-coated lymphoma cells, whereas populations that released 
very little H202 in response to PMA  (1)  mediated little or no antibody-dependent 
cytotoxicity. Peritoneal granulocytes represented an  exception to  this  relationship. 
Granulocytes both secreted H20~ (1) and lysed lymphoma cells (2) in the presence of 
PMA, but were ineffective in antibody-induced cytolysis under the conditions tested. 
In man, granulocytes can participate in antibody-dependent cytotoxicity (8, 34, 42, 
43), but appear to require a higher density of antibody molecules on the target cells 
than do mononuclear effectors (34). 
E:T ratios are commonly used to compare the potency of cytotoxic processes. At 
low E:T ratios,  PMA-induced cytolysis was  more potent  than antibody-dependent 
cytolysis (not shown). However, the latter comparison may be misleading. Antibody- 
dependent cytolysis, unlike PMA-induced cytolysis, required cell-cell contact. Scan- 
ning electron microscopy showed that  one antibody-coated tumor cell was  usually 
associated with only one macrophage. With TLX9 at  higher E:T ratios, antibody- 
dependent and PMA-induced cytotoxicity gave essentially the same results (Table I). 
Under some conditions, sensitized tumor cells are phagocytized by macrophages 
(44, 45). We did not observe phagocytosis of sensitized tumor cells, as assessed either 
by retention of S~Cr or by scanning electron microscopy. A particle must be opsonized 
globally to  be engulfed by a  macrophage  (46).  Perhaps  redistribution  of immune 
complexes on the tumor cell surface is one factor which determines whether extracel- 
lular lysis will predominate over endocytosis. 
We found earlier that activated macrophages, when pharmacologically triggered, 
killed extracellular tumor cells by oxidative means  (2,  3).  In  the present  study, an 
extracellular lytic response of similar potency was elicited from the same mononuclear 
effector  cell  populations  without  pharmacologic  agents.  Cytolysis  was  triggered, 
instead,  by a  physiologic substance--that  is,  antibody.  Whether the  latter form of 
cytolysis may also have an oxidative basis is the subject of the accompanying report 
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Summary 
Treatment of mice with Bacille Calmette-Gu~rin (BCG) or C. paroum activates their 
peritoneal  macrophages to release increased  amounts of H202,  and  thereby to lyse 
extracellular  tumor cells,  in  response to a  pharmacologic agent,  phorbol  myristate 
acetate  (PMA)  (1-3).  In  the  present  study,  the  same  bacterial  vaccines  activated 
peritoneal cells to become cytolytic to lymphoma cells sensitized with alloantiserum, 
in the absence of PMA. Resident peritoneal cells, or those elicited with thioglycollate 
broth, were ineffective, not only in PMA-induced lysis, but also in antibody-dependent 
lysis of tumor cells.  The cytolytic effect of BCG  peritoneal  cells  toward  sensitized 
tumor  cells  appeared  to  be  mediated  mostly  by  macrophages.  Cytotoxicity  was 
immunologically  specific,  contact  dependent,  rapid,  and  efficient.  Phagocytosis of 
intact tumor cells was not involved. Alloantiserum-dependent cytolysis was specifically 
blocked by the Fab fragment of a  monoclonal antibody directed against the trypsin- 
resistant macrophage Fc receptor (FcR II). Thus, tumor cells coated with homologous 
immunoglobulin interact with FcR II on activated macrophages to trigger an extra- 
cellular cytolytic response. 
We are grateful to R. Steinman for 1.1 antibody; to S. Silverstein  for discussions; to R. Keller, 
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